‹ ›
MYP_105876
← PREVIOUS NEXT → BACK
Basic Information
Murepavadin
Antimicrobial ▸ Antibacterial
not Standard
14 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
ASPPTWIXXXXWXX
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0331357 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protegrin-inspired cyclic peptide
32630
Structure & Mods
cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
Dab/Orn and D-residues
Bio-Activity Profile
Antibacterial
Pseudomonas aeruginosa clinical isolates
0.12 μg/mL
MIC50
PaperAntimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China PMID29686157 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/29686157/
RECORD: Rec_0414637 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protegrin-inspired cyclic peptide
32630
Structure & Mods
cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
Dab/Orn and D-residues
Bio-Activity Profile
Antibacterial
Pseudomonas aeruginosa clinical isolates
0.12 μg/mL
MIC90
PaperAntimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China PMID29686157 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/29686157/